nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Hypotension—Azathioprine—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Remifentanil—Cardiac arrest—Prednisone—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Remifentanil—Tremor—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Remifentanil—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Remifentanil—Nervous system disorder—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Remifentanil—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Remifentanil—Pruritus—Mometasone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Remifentanil—Tachycardia—Leflunomide—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Remifentanil—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Remifentanil—Anaemia—Lisinopril—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Remifentanil—Skin disorder—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Remifentanil—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Remifentanil—Confusional state—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Remifentanil—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Remifentanil—Body temperature increased—Captopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Remifentanil—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Remifentanil—Oedema—Mycophenolic acid—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Remifentanil—Nausea—Pentoxifylline—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Remifentanil—Chills—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Remifentanil—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Remifentanil—Diarrhoea—Mometasone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Remifentanil—Hypokalaemia—Prednisone—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Remifentanil—Syncope—Lisinopril—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Remifentanil—Shock—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Remifentanil—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Remifentanil—Hypotension—Leflunomide—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Remifentanil—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Remifentanil—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Remifentanil—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Remifentanil—Loss of consciousness—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Remifentanil—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Remifentanil—Cough—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Remifentanil—Visual disturbance—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Remifentanil—Paraesthesia—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Remifentanil—Anxiety—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Remifentanil—Dyspnoea—Leflunomide—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Remifentanil—Hypotension—Mycophenolic acid—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Remifentanil—Dyspepsia—Leflunomide—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Remifentanil—Vomiting—Mometasone—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Remifentanil—Dry mouth—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Remifentanil—Feeling abnormal—Azathioprine—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Remifentanil—Rash—Mometasone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Remifentanil—Dermatitis—Mometasone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Remifentanil—Confusional state—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Remifentanil—Headache—Mometasone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Remifentanil—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Remifentanil—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Oedema—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Pruritus—Captopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Pain—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Constipation—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Remifentanil—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Remifentanil—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Remifentanil—Somnolence—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Remifentanil—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Remifentanil—Shock—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Remifentanil—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Remifentanil—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Remifentanil—Tachycardia—Lisinopril—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Remifentanil—Body temperature increased—Azathioprine—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Remifentanil—Skin disorder—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Remifentanil—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Remifentanil—Diarrhoea—Captopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Remifentanil—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Remifentanil—Feeling abnormal—Leflunomide—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Remifentanil—Nausea—Mometasone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Remifentanil—Pain—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Remifentanil—Constipation—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Remifentanil—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Remifentanil—Hyperglycaemia—Prednisone—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Remifentanil—Cough—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Remifentanil—Hypotension—Lisinopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Remifentanil—Dizziness—Captopril—systemic scleroderma	0.001	0.001	CcSEcCtD
Remifentanil—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Remifentanil—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Remifentanil—Urticaria—Leflunomide—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Remifentanil—Body temperature increased—Leflunomide—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Remifentanil—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00098	0.00098	CcSEcCtD
Remifentanil—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Remifentanil—Hypersensitivity—Azathioprine—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Remifentanil—Paraesthesia—Lisinopril—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Remifentanil—Vomiting—Captopril—systemic scleroderma	0.000962	0.000962	CcSEcCtD
Remifentanil—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Remifentanil—Dyspnoea—Lisinopril—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Remifentanil—Rash—Captopril—systemic scleroderma	0.000954	0.000954	CcSEcCtD
Remifentanil—Dermatitis—Captopril—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Remifentanil—Somnolence—Lisinopril—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Remifentanil—Headache—Captopril—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Remifentanil—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000947	0.000947	CcSEcCtD
Remifentanil—Dyspepsia—Lisinopril—systemic scleroderma	0.000943	0.000943	CcSEcCtD
Remifentanil—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Remifentanil—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Remifentanil—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000925	0.000925	CcSEcCtD
Remifentanil—Shock—Mycophenolate mofetil—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Remifentanil—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000921	0.000921	CcSEcCtD
Remifentanil—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Remifentanil—Hypersensitivity—Leflunomide—systemic scleroderma	0.000919	0.000919	CcSEcCtD
Remifentanil—Constipation—Lisinopril—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Remifentanil—Pain—Lisinopril—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Remifentanil—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Remifentanil—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Remifentanil—Bradycardia—Prednisone—systemic scleroderma	0.000912	0.000912	CcSEcCtD
Remifentanil—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Remifentanil—Diarrhoea—Azathioprine—systemic scleroderma	0.000903	0.000903	CcSEcCtD
Remifentanil—Haemoglobin—Prednisone—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Remifentanil—Nausea—Captopril—systemic scleroderma	0.000899	0.000899	CcSEcCtD
Remifentanil—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000897	0.000897	CcSEcCtD
Remifentanil—Haemorrhage—Prednisone—systemic scleroderma	0.000896	0.000896	CcSEcCtD
Remifentanil—Hallucination—Prednisone—systemic scleroderma	0.000891	0.000891	CcSEcCtD
Remifentanil—Feeling abnormal—Lisinopril—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Remifentanil—Pruritus—Leflunomide—systemic scleroderma	0.000882	0.000882	CcSEcCtD
Remifentanil—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000877	0.000877	CcSEcCtD
Remifentanil—Dysuria—Methotrexate—systemic scleroderma	0.000875	0.000875	CcSEcCtD
Remifentanil—Dizziness—Azathioprine—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Remifentanil—Diarrhoea—Leflunomide—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Remifentanil—Urticaria—Lisinopril—systemic scleroderma	0.000851	0.000851	CcSEcCtD
Remifentanil—Body temperature increased—Lisinopril—systemic scleroderma	0.000847	0.000847	CcSEcCtD
Remifentanil—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Remifentanil—Pruritus—Mycophenolic acid—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Remifentanil—Vomiting—Azathioprine—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Remifentanil—Pneumonia—Methotrexate—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Remifentanil—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Remifentanil—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Remifentanil—Rash—Azathioprine—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Remifentanil—Dermatitis—Azathioprine—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Remifentanil—Flushing—Prednisone—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Remifentanil—Headache—Azathioprine—systemic scleroderma	0.000827	0.000827	CcSEcCtD
Remifentanil—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000826	0.000826	CcSEcCtD
Remifentanil—Dizziness—Leflunomide—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Remifentanil—Renal failure—Methotrexate—systemic scleroderma	0.00082	0.00082	CcSEcCtD
Remifentanil—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Remifentanil—Angiopathy—Prednisone—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Remifentanil—Immune system disorder—Prednisone—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Remifentanil—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Remifentanil—Pain—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Remifentanil—Arrhythmia—Prednisone—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Remifentanil—Sweating—Methotrexate—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Remifentanil—Haematuria—Methotrexate—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Remifentanil—Vomiting—Leflunomide—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Remifentanil—Hypersensitivity—Lisinopril—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Remifentanil—Dizziness—Mycophenolic acid—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Remifentanil—Rash—Leflunomide—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Remifentanil—Dermatitis—Leflunomide—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Remifentanil—Nausea—Azathioprine—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Remifentanil—Headache—Leflunomide—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Remifentanil—Erythema—Prednisone—systemic scleroderma	0.00078	0.00078	CcSEcCtD
Remifentanil—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Remifentanil—Pruritus—Lisinopril—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Remifentanil—Vomiting—Mycophenolic acid—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Remifentanil—Haemoglobin—Methotrexate—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Remifentanil—Rash—Mycophenolic acid—systemic scleroderma	0.00075	0.00075	CcSEcCtD
Remifentanil—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Remifentanil—Haemorrhage—Methotrexate—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Remifentanil—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Remifentanil—Headache—Mycophenolic acid—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Remifentanil—Pharyngitis—Methotrexate—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Remifentanil—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Remifentanil—Nausea—Leflunomide—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Remifentanil—Diarrhoea—Lisinopril—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Remifentanil—Visual impairment—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Remifentanil—Anaemia—Prednisone—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Remifentanil—Agitation—Prednisone—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Remifentanil—Dizziness—Lisinopril—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Remifentanil—Nausea—Mycophenolic acid—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Remifentanil—Syncope—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Remifentanil—Cardiac disorder—Methotrexate—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Remifentanil—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Remifentanil—Vomiting—Lisinopril—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Remifentanil—Rash—Lisinopril—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Remifentanil—Convulsion—Prednisone—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Remifentanil—Dermatitis—Lisinopril—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Remifentanil—Hypertension—Prednisone—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Remifentanil—Chills—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Remifentanil—Headache—Lisinopril—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Remifentanil—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000664	0.000664	CcSEcCtD
Remifentanil—Anxiety—Prednisone—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Remifentanil—Erythema—Methotrexate—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Remifentanil—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Remifentanil—Nausea—Lisinopril—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Remifentanil—Oedema—Prednisone—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Remifentanil—Shock—Prednisone—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Remifentanil—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—systemic scleroderma	0.000618	0.000618	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—systemic scleroderma	0.000615	0.000615	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Remifentanil—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Remifentanil—Rash—Mycophenolate mofetil—systemic scleroderma	0.000592	0.000592	CcSEcCtD
Remifentanil—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000591	0.000591	CcSEcCtD
Remifentanil—Headache—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Remifentanil—Paraesthesia—Prednisone—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Remifentanil—Cough—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Remifentanil—Dyspepsia—Prednisone—systemic scleroderma	0.00056	0.00056	CcSEcCtD
Remifentanil—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000551	0.000551	CcSEcCtD
Remifentanil—Constipation—Prednisone—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000521	0.000521	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Remifentanil—Urticaria—Prednisone—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—systemic scleroderma	0.000497	0.000497	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Remifentanil—Pain—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Remifentanil—Pruritus—Prednisone—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Remifentanil—Diarrhoea—Prednisone—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Remifentanil—Dizziness—Prednisone—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Remifentanil—Vomiting—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Remifentanil—Rash—Prednisone—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Remifentanil—Headache—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Remifentanil—Nausea—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—systemic scleroderma	0.000376	0.000376	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Remifentanil—Rash—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—systemic scleroderma	0.000335	0.000335	CcSEcCtD
Remifentanil—Headache—Methotrexate—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Remifentanil—Nausea—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
